Chondrocytes extract from patients with osteoarthritis induces chondrogenesis in infrapatellar fat pad-derived stem cells

Osteoarthritis and Cartilage

Volumn 21, Issue 1, 2013, Pages 246-258

  Lopez Ruiz E ^a   Peran M ^a   Cobo Molinos, J ^a   Jimenez G ^b,c   Picon M ^b   Bustamante, M ^d   Arrebola, F ^c   Hernandez Lamas M C ^e   Delgado Martinez A D ^a   Montanez E ^f   Marchal, J A ^b,c  

^a UNIVERSITY OF JAÉN   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e Centro de Transfusión   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Cell extracts; Chondrogenic differentiation; Infrapatellar fat pad derived stem cells; Osteoarthritis (OA); Poly (dl lactic co glycolic acid) (PLGA) scaffolds

Indexed keywords

5' NUCLEOTIDASE; AGGRECAN; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL EXTRACT; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; COLLAGEN TYPE 2; ENDOGLIN; MESSENGER RNA; POLYGLACTIN; PROTEOGLYCAN; STREPTOLYSIN O; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL STRUCTURE; CELL TRANSDIFFERENTIATION; CELL VACUOLE; CELLULAR DISTRIBUTION; CHONDROGENESIS; CLINICAL ARTICLE; CYTOPLASM; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFRAPATELLAR FAT PAD DERIVED STEM CELL; KNEE OSTEOARTHRITIS; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION;

CELL TRANSDIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOARTHRITIS, KNEE; PATELLA; PROTEOGLYCANS; TISSUE SCAFFOLDS;

EID: 84871924934     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.10.007     Document Type: Article

References (51)

1. Ronn K., Reischl N., Gautier E., Jacobi M. Current surgical treatment of knee osteoarthritis. Arthritis 2011, 2011:454873.
2. Curl W.W., Krome J., Gordon E.S., Rushing J., Smith B.P., Poehling G.G. Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy 1997, 13:456-460.
3. Groen J.W., Stevens M., Kersten R.F., Reininga I.H., van den Akker-Scheek I. After total knee arthroplasty, many people are not active enough to maintain their health and fitness: an observational study. J Physiother 2012, 58:113-116.
4. Hardingham T.E., Oldershaw R.A., Tew S.R. Cartilage, SOX9 and Notch signals in chondrogenesis. J Anat 2006, 209:469-480.
5. Ochi M., Uchio Y., Kawasaki K., Wakitani S., Iwasa J. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 2002, 84:571-578.
6. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895.
7. de la Fuente R., Abad J.L., Garcia-Castro J., Fernandez-Miguel G., Petriz J., Rubio D., et al. Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res 2004, 297:313-328.
8. Ding D.C., Shyu W.C., Lin S.Z. Mesenchymal stem cells. Cell Transplant 2011, 20:5-14.
9. Im G.I., Kim D.Y., Shin J.H., Hyun C.W., Cho W.H. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg Br 2001, 83:289-294.
10. English A., Jones E.A., Corscadden D., Henshaw K., Chapman T., Emery P., et al. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford) 2007, 46:1676-1683.
11. Buckley C.T., Vinardell T., Thorpe S.D., Haugh M.G., Jones E., McGonagle D., et al. Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. J Biomech 2010, 43:920-926.
12. Jurgens W.J., van Dijk A., Doulabi B.Z., Niessen F.B., Ritt M.J., van Milligen F.J., et al. Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy 2009, 11:1052-1064.
13. Dragoo J.L., Samimi B., Zhu M., Hame S.L., Thomas B.J., Lieberman J.R., et al. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003, 85:740-747.
14. Peran M., Marchal J.A., Rodriguez-Serrano F., Alvarez P., Aranega A. Transdifferentiation: why and how?. Cell Biol Int 2011, 35:373-379.
15. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells 2007, 25:2896-2902.
16. Eberhard D., Tosh D. Transdifferentiation and metaplasia as a paradigm for understanding development and disease. Cell Mol Life Sci 2008, 65:33-40.
17. Peran M., Sanchez-Ferrero A., Tosh D., Marchal J.A., Lopez E., Alvarez P., et al. Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells. Cytotherapy 2011, 13:193-200.
18. Hakelien A.M., Gaustad K.G., Collas P. Transient alteration of cell fate using a nuclear and cytoplasmic extract of an insulinoma cell line. Biochem Biophys Res Commun 2004, 316:834-841.
19. Collas P., Taranger C.K. Epigenetic reprogramming of nuclei using cell extracts. Stem Cell Rev 2006, 2:309-317.
20. Marchal J.A., Picon M., Peran M., Bueno C., Jimenez-Navarro M., Carrillo E., et al. Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration. Stem Cells Dev 2012, 21:562-574.
21. Hakelien A.M., Gaustad K.G., Collas P. Modulation of cell fate using nuclear and cytoplasmic extracts. Methods Mol Biol 2006, 325:99-114.
22. Gaustad K.G., Boquest A.C., Anderson B.E., Gerdes A.M., Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun 2004, 314:420-427.
23. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
24. Peran M., Garcia M.A., Lopez-Ruiz E., Bustamante M., Jimenez G., Madeddu R., et al. Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci 2012, 13:3847-3886.
25. Albrecht C., Tichy B., Nurnberger S., Hosiner S., Zak L., Aldrian S., et al. Gene expression and cell differentiation in matrix-associated chondrocyte transplantation grafts: a comparative study. Osteoarthritis Cartilage 2011, 19:1219-1227.
26. Peran M., Marchal J.A., Lopez E., Jimenez-Navarro M., Boulaiz H., Rodriguez-Serrano F., et al. Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy 2010, 12:332-337.
27. Khan W.S., Adesida A.B., Tew S.R., Longo U.G., Hardingham T.E. Fat pad-derived mesenchymal stem cells as a potential source for cell-based adipose tissue repair strategies. Cell Prolif 2012, 45:111-120.
28. Buckley C.T., Vinardell T., Kelly D.J. Oxygen tension differentially regulates the functional properties of cartilaginous tissues engineered from infrapatellar fat pad derived MSCs and articular chondrocytes. Osteoarthritis Cartilage 2010, 18:1345-1354.
29. Varghese S., Theprungsirikul P., Sahani S., Hwang N., Yarema K.J., Elisseeff J.H. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage 2007, 15:59-68.
30. Diaz-Romero J., Gaillard J.P., Grogan S.P., Nesic D., Trub T., Mainil-Varlet P. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol 2005, 202:731-742.
31. O'Sullivan J., D'Arcy S., Barry F.P., Murphy J.M., Coleman C.M. Mesenchymal chondroprogenitor cell origin and therapeutic potential. Stem Cell Res Ther 2011, 2:8.
32. Wickham M.Q., Erickson G.R., Gimble J.M., Vail T.P., Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res 2003, 412:196-212.
33. Pabbruwe M.B., Esfandiari E., Kafienah W., Tarlton J.F., Hollander A.P. Induction of cartilage integration by a chondrocyte/collagen-scaffold implant. Biomaterials 2009, 30:4277-4286.
34. Fioravanti A., Cantarini L., Chellini F., Manca D., Paccagnini E., Marcolongo R., et al. Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure. Osteoarthritis Cartilage 2005, 13:688-696.
35. Yamashita S., Andoh M., Ueno-Kudoh H., Sato T., Miyaki S., Asahara H. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 2009, 315:2231-2240.
36. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997, 17:2336-2346.
37. Lefebvre V., Li P., de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 1998, 17:5718-5733.
38. Han Y., Lefebvre V. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 2008, 28:4999-5013.
39. Steinert A.F., Proffen B., Kunz M., Hendrich C., Ghivizzani S.C., Noth U., et al. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 2009, 11:R148.
40. Mwale F., Stachura D., Roughley P., Antoniou J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res 2006, 24:1791-1798.
41. Dessau W., von der Mark H., von der Mark K., Fischer S. Changes in the patterns of collagens and fibronectin during limb-bud chondrogenesis. J Embryol Exp Morphol 1980, 57:51-60.
42. Chen C.C., Liao C.H., Wang Y.H., Hsu Y.M., Huang S.H., Chang C.H., et al. Cartilage fragments from osteoarthritic knee promote chondrogenesis of mesenchymal stem cells without exogenous growth factor induction. J Orthop Res 2012, 30:393-400.
43. Tallheden T., Karlsson C., Brunner A., Van Der Lee J., Hagg R., Tommasini R., et al. Gene expression during redifferentiation of human articular chondrocytes. Osteoarthritis Cartilage 2004, 12:525-535.
44. Toghraie F.S., Chenari N., Gholipour M.A., Faghih Z., Torabinejad S., Dehghani S., et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee 2011, 18:71-75.
45. Buckley C.T., Kelly D.J. Expansion in the presence of FGF-2 enhances the functional development of cartilaginous tissues engineered using infrapatellar fat pad derived MSCs. J Mech Behav Biomed Mater 2012, 11:102-111.
46. Khan W.S., Adesida A.B., Hardingham T.E. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 2007, 9:R55.
47. Khan W.S., Tew S.R., Adesida A.B., Hardingham T.E. Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther 2008, 10:R74.
48. Benya P.D., Shaffer J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982, 30:215-224.
49. Melton J.T., Wilson A.J., Chapman-Sheath P., Cossey A.J. TruFit CB bone plug: chondral repair, scaffold design, surgical technique and early experiences. Expert Rev Med Devices 2010, 7:333-341.
50. Park G.E., Pattison M.A., Park K., Webster T.J. Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials 2005, 26:3075-3082.
51. Li W.C., Yu W.Y., Quinlan J.M., Burke Z.D., Tosh D. The molecular basis of transdifferentiation. J Cell Mol Med 2005, 9:569-582.